Unidad de Revisiones Sistemáticas y Meta-análisis

Medicina y ciencias biológicas

1. Systematic Reviews 100%
2. Meta-Analysis 89%
3. Confidence Intervals 41%
4. Peru 34%
5. Randomized Controlled Trials 33%
6. Coronavirus 32%
7. Mortality 21%
8. Latin America 21%
9. Hydroxychloroquine 18%
10. Odds Ratio 14%
11. Dyspepsia 14%
12. Pandemics 13%
13. Pancreatitis 11%
14. Lipids 10%
15. Databases 10%
16. Therapeutics 10%
17. Hemorrhage 9%
18. Helicobacter pylori 9%
19. Intention 9%
20. Cohort Studies 8%
21. Network Meta-Analysis 8%
22. Hydroxymethylglutaryl-CoA Reductase Inhibitors 7%
23. Coronary Artery Disease 7%
24. Gastrointestinal Endoscopy 7%
25. Restrictive Cardiomyopathy 7%
26. Safety 7%
27. APACHE 7%
28. Constrictive Pericarditis 7%
29. Liraglutide 7%
30. Vaccination 7%
31. Biopsy 6%
32. Melena 6%
33. Atrial Fibrillation 6%
34. Autoimmune Hepatitis 6%
35. Choriocarcinoma 6%
36. Endoscopic Mucosal Resection 6%
37. Pericarditis 6%
38. Blood Pressure 6%
39. Social Security 6%
40. Gastroenterology 6%
41. Dietary Supplements 6%
42. Myocardial Infarction 5%
43. Observational Studies 5%
44. Infections 5%
45. Chloroquine 5%
46. Obesity 5%
47. Heart Failure 5%
48. Hospitalization 5%
49. PubMed 5%
50. Endoscopy 5%
51. Depression 5%
52. Lopinavir 5%
53. Acute Coronary Syndrome 5%
54. Hematemesis 5%
55. Placebos 5%